Ask the MD: Medical Marijuana and Parkinson’s Disease

Ask the MD: Medical Marijuana and Parkinson’s Disease

Publication date: Oct 11, 2019

Does medical marijuana help Parkinson’s symptoms? Rachel Dolhun, MD, movement disorder specialist and vice president of medical communications at The Michael J. Fox Foundation, answers this and other common questions about medical marijuana and Parkinson’s disease.

The “Ask the MD” series is intended as an educational resource for people with Parkinson’s and their loved ones. Please consult with your personal healthcare provider to address individual medical questions.

The Michael J. Fox Foundation for Parkinson’s Research is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today. https://www.michaeljfox.org

We gratefully acknowledge the Steering Committee members of our Patient Disease Education Consortium in conjunction with The Albert B. Glickman Parkinson’s Disease Education Program and Charles B. Moss Jr. and family, whose sponsorship allows us to create and distribute materials, while preserving our track record of efficiency in stewarding donor-raised contributions for maximum impact on Parkinson’s drug development. Sponsorship support does not influence MJFF’s content perspective or panelist selection.

Note: Tap cc in the lower right corner of the player to enable auto-generated captions for the video.

Concepts Keywords
Air Dyskinesia
Cannabinoid Mood hallucinations
Cannabinoids Placebo
CBD Chemicals
Dopa Medical specialties
Drug Development Medicine
Dyskinesia Appetite stimulants
FDA Entheogens
Hallucinations Euphoriants
Healthcare Branches of biology
Leva Cannabis smoking
Marijuana Medicinal plants
Memory Parkinson
Movement Disorder Tetrahydrocannabinol
Parkinson Drug development
Placebo
Sleep
Stiffness
Tremor

Semantics

Type Source Name
gene UNIPROT DBF4
gene UNIPROT ARSK
drug DRUGBANK Medical Cannabis
disease MESH movement disorder
disease MESH development
drug DRUGBANK Nonoxynol-9
gene UNIPROT IMPACT
gene UNIPROT NXF1
gene UNIPROT SEC14L2
gene UNIPROT USO1
gene UNIPROT FLNB

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *